Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 2026 AL 2040

The APOE ε4 variant and hippocampal atrophy in Alzheimer's disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance

Saeed U, Desmarais P, Masellis M.

Expert Rev Neurother. 2021 Aug;21(8):851-870. doi: 10.1080/14737175.2021.1956904. Epub 2021 Aug 13.

Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease

Oliveira LMA, Gasser T, Edwards R, Zweckstetter M, Melki R, Stefanis L, Lashuel HA, Sulzer D, Vekrellis K, Halliday GM, Tomlinson JJ, Schlossmacher M, Jensen PH, Schulze-Hentrich J, Riess O, Hirst WD, El-Agnaf O, Mollenhauer B, Lansbury P, Outeiro TF.

NPJ Parkinsons Dis. 2021 Jul 26;7(1):65. doi: 10.1038/s41531-021-00203-9.

Covid-19 and Parkinson's disease: an overview

Cartella SM, Terranova C, Rizzo V, Quartarone A, Girlanda P.

J Neurol. 2021 Dec;268(12):4415-4421. doi: 10.1007/s00415-021-10721-4. Epub 2021 Jul 27.

Hot Topics in Recent Parkinson's Disease Research: Where We are and Where We Should Go

Li S, Jia C, Li T, Le W.

Neurosci Bull. 2021 Dec;37(12):1735-1744. doi: 10.1007/s12264-021-00749-x. Epub 2021 Jul 27.

Chronic subdural hematoma-induced parkinsonism: A systematic review

Fahmi A, Kustono H, Adhistira KS, Subianto H, Utomo B, Turchan A.

Clin Neurol Neurosurg. 2021 Sep;208:106826. doi: 10.1016/j.clineuro.2021.106826. Epub 2021 Jul 21.

Mild cognitive impairment and abnormal brain metabolic expression in idiopathic REM sleep behavior disorder

Yoo D, Lee JY, Kim YK, Yoon EJ, Kim H, Kim R, Nam H, Jeon B.

Parkinsonism Relat Disord. 2021 Sep;90:1-7. doi: 10.1016/j.parkreldis.2021.07.022. Epub 2021 Jul 22.

Frailty in Parkinson's disease: A systematic review and meta-analysis

McMillan JM, Michalchuk Q, Goodarzi Z.

Clin Park Relat Disord. 2021 May 25;4:100095. doi: 10.1016/j.prdoa.2021.100095. eCollection 2021.

Non-pharmacologic interventions to treat apathy in Parkinson's disease: A realist review

Mele B, Ismail Z, Goodarzi Z, Pringsheim T, Lew G, Holroyd-Leduc J.

Clin Park Relat Disord. 2021 May 25;4:100096. doi: 10.1016/j.prdoa.2021.100096. eCollection 2021.

Severe Heart Failure Associated With Tachycardia-Induced Cardiomyopathy Due to Incessant Atrioventricular Re-Entrant Tachycardia

Moulin T, Landes R, Ouazana V, Abehsira G, Lim P, Huguet R, Damy T, Teiger E, Lellouche N, Hamon D.

JACC Case Rep. 2021 Feb 3;3(3):479-483. doi: 10.1016/j.jaccas.2020.11.028. eCollection 2021 Mar.

Lower urinary tract dysfunction in Parkinsonian syndromes

Vichayanrat E, Hentzen C, Batla A, Simeoni S, Iodice V, Panicker JN.

Neurol Sci. 2021 Oct;42(10):4045-4054. doi: 10.1007/s10072-021-05411-y. Epub 2021 Jul 28.

Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson's disease: a pilot study

Yoritaka A, Kobayashi Y, Hayashi T, Saiki S, Hattori N.

Neurol Sci. 2021 Nov;42(11):4767-4770. doi: 10.1007/s10072-021-05489-4. Epub 2021 Jul 28.

The Emerging Role of Circular RNAs in Alzheimer's Disease and Parkinson's Disease

Zhang M, Bian Z.

Front Aging Neurosci. 2021 Jul 12;13:691512. doi: 10.3389/fnagi.2021.691512. eCollection 2021.

Necroptosis: A Novel Pathway in Neuroinflammation

Yu Z, Jiang N, Su W, Zhuo Y.

Front Pharmacol. 2021 Jul 12;12:701564. doi: 10.3389/fphar.2021.701564. eCollection 2021.

Polypharmacy in Chronic Neurological Diseases: Multiple Sclerosis, Dementia and Parkinson's Disease

Frahm N, Hecker M, Zettl UK.

Curr Pharm Des. 2021;27(38):4008-4016. doi: 10.2174/1381612827666210728102832.

The protective, rescue and therapeutic potential of multi-target iron-chelators for retinitis pigmentosa

Lin B, Youdim MBH.

Free Radic Biol Med. 2021 Oct;174:1-11. doi: 10.1016/j.freeradbiomed.2021.07.031. Epub 2021 Jul 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias